Z-ligustilide ameliorated ultraviolet B-induced oxidative stress and inflammatory cytokine production in human keratinocytes through upregulation of Nrf2/HO-1 and suppression of NF-κB pathway

Experimental Dermatology

Volumn 24, Issue 9, 2015, Pages 703-708

  Wu, Zhouwei ^a,b   Uchi, Hiroshi ^b   Morino Koga, Saori ^b   Shi, Weimin ^a   Furue, Masutaka ^b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Keratinocytes; NF B; Nrf2; Ultraviolet B; Z ligustilide

Indexed keywords

CYTOKINE; HEME OXYGENASE 1; I KAPPA B KINASE ALPHA; INTERLEUKIN 6; INTERLEUKIN 8; LIGUSTILIDE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTOPORPHYRIN TIN; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR NRF2; TRANSCRIPTION FACTOR RELA; CCL2 PROTEIN, HUMAN; GAMMA BUTYROLACTONE; HMOX1 PROTEIN, HUMAN; I KAPPA B; NFE2L2 PROTEIN, HUMAN; PLANT EXTRACT;

ANGELICA; ANGELICA ACUTILOBA; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CNIDIUM; CNIDIUM OFFICINALE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DRUG MECHANISM; GENE EXPRESSION; HUMAN; HUMAN CELL; KERATINOCYTE; NORMAL HUMAN; OXIDATIVE STRESS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RADIATION EXPOSURE; RADIATION INJURY; RADIATION PROTECTION; SKIN PROTECTION; ULTRAVIOLET B RADIATION; UPREGULATION; ANALOGS AND DERIVATIVES; CELL CULTURE; CELL SURVIVAL; DRUG EFFECTS; GENE SILENCING; GENETIC TRANSFECTION; GENETICS; METABOLISM; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; ULTRAVIOLET RADIATION;

4-BUTYROLACTONE; CELL SURVIVAL; CELLS, CULTURED; CHEMOKINE CCL2; GENE SILENCING; HEME OXYGENASE-1; HUMANS; I-KAPPA B PROTEINS; INTERLEUKIN-6; INTERLEUKIN-8; KERATINOCYTES; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; PLANT EXTRACTS; PROTEIN TRANSPORT; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELA; TRANSFECTION; ULTRAVIOLET RAYS; UP-REGULATION;

EID: 84939171081     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12758     Document Type: Article

References (44)

1. Syed D N, Afaq F, Mukhtar H. Photochem Photobiol 2012: 88: 1184-1190.
2. English J S, Dawe R S, Ferguson J. Br Med Bull 2003: 68: 129-142.
3. Kregel K C, Zhang H J. Am J Physiol Regul Integr Comp Physiol 2007: 292: R18-R36.
4. Itoh K, Wakabayashi N, Katoh Y et al. Genes Dev 1999: 13: 76-86.
5. Wei Y, Liu X M, Peyton K J et al. Am J Physiol Cell Physiol 2009: 297: C907-C915.
6. Kaspar J W, Niture S K, Jaiswal A K. Free Radic Biol Med 2009: 47: 1304-1309.
7. Monfrecola G, Gaudiello F, Cirillo T et al. Clin Exp Dermatol 2013: 38: 185-188.
8. Vicentini F T, He T, Shao Y et al. J Dermatol Sci 2011: 61: 162-168.
9. Ghosh S, Hayden M S. Nat Rev Immunol 2008: 8: 837-848.
10. Lee S H, Toth Z, Wong L Y et al. mBio 2012: 3: e00411-e00412.
11. Hu H, Brittain G C, Chang J H et al. Nature 2013: 494: 371-374.
12. Soysa N S, Alles N. Biochem Biophys Res Commun 2009: 378: 1-5.
13. Qi H, Han Y, Rong J. Neuropharmacology 2012: 62: 1659-1670.
14. Peng H Y, Du J R, Zhang G Y et al. Biol Pharm Bull 2007: 30: 309-312.
15. Nishimura K, Osawa T, Watanabe K. Evid Based Complement Alternat Med 2011: 2011: 812163.
16. Peng B, Zhao P, Lu Y P et al. Brain Res 2013: 1520: 168-177.
17. Wang J, Du J R, Wang Y et al. Acta Pharmacol Sin 2010: 31: 791-797.
18. Wu Z, Uchi H, Morino-Koga S et al. Exp Dermatol 2014: 23: 260-265.
19. Muta-Takada K, Terada T, Yamanishi H et al. BioFactors 2009: 35: 435-441.
20. Rijnkels J M, Moison R M, Podda E et al. Radiat Res 2003: 159: 210-217.
21. Karin M, Greten F R. Nat Rev Immunol 2005: 5: 749-759.
22. Li Q, Verma I M. Nat Rev Immunol 2002: 2: 725-734.
23. Cho S Y, Park S J, Kwon M J et al. Mol Cell Biochem 2003: 243: 153-160.
24. Kundu J K, Surh Y J. Mutat Res 2005: 591: 123-146.
25. Lee S, Kim K H, Park C et al. Exp Dermatol 2014: 23(Suppl 1): 13-17.
26. Yoshihisa Y, Rehman M U, Shimizu T. Exp Dermatol 2014: 23: 178-183.
27. Park G, Kim H G, Sim Y et al. Biol Pharm Bull 2013: 36: 1134-1139.
28. Scharffetter-Kochanek K, Brenneisen P, Wenk J et al. Exp Gerontol 2000: 35: 307-316.
29. Yu Y, Du J R, Wang C Y et al. Exp Brain Res 2008: 184: 307-312.
30. Svobodova A, Psotova J, Walterova D. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2003: 147: 137-145.
31. Narayanan B A, Narayanan N K, Davis L et al. Mol Cancer Ther 2006: 5: 1117-1125.
32. Kim N, Hwangbo C, Lee S et al. Phytother Res 2013: 27: 1700-1707.
33. Chen J S, Huang P H, Wang C H et al. Atherosclerosis 2011: 214: 301-309.
34. Afaq F, Adhami V M, Ahmad N et al. Oncogene 2003: 22: 1035-1044.
35. Minelli A, Grottelli S, Mierla A et al. Int J Biochem Cell Biol 2012: 44: 525-535.
36. Paur I, Balstad T R, Blomhoff R. Free Radic Biol Med 2010: 48: 1218-1227.
37. Checker R, Patwardhan R S, Sharma D et al. Free Radic Biol Med 2012: 53: 1421-1430.
38. Kumar K J, Yang H L, Tsai Y C et al. Food Chem Toxicol 2013: 59: 55-66.
39. Buelna-Chontal M, Zazueta C. Cell Signal 2013: 25: 2548-2557.
40. Sun Z, Huang Z, Zhang D D. PLoS ONE 2009: 4: e6588.
41. Liu G H, Qu J, Shen X. Biochim Biophys Acta 2008: 1783: 713-727.
42. Bellezza I, Mierla A L, Minelli A. Cancers 2010: 2: 483-497.
43. Dietz B M, Liu D, Hagos G K et al. Chem Res Toxicol 2008: 21: 1939-1948.
44. Leung T H, Zhang L F, Wang J et al. J Clin Investig 2013: 123: 5361-5370.